|
|
|
|
Intrasphere Technologies, a technology-consulting firm with a core focus on the Life Sciences, came to BlinnPR with no internal PR staff and only a part-time marketing director. The company had promising sales leads but few deals, and a shoestring budget for all operations. Intrasphere wanted to generate sales leads by breaking into the fray of press discussions dominated by powerhouses like BearingPoint and IBM.
BlinnPR began pounding the pavement to get Intrasphere name known in the Life Science community. With a 12 month program dedicating to introducing and exposing the company and its products to the vertical and trade press, BlinnPR worked to make Intrasphere a name on the tip of every decision-maker in the Life Sciences space. BlinnPR capitalized on the stellar and growing list of household name customers - Pfizer Inc., Schering-Plough Corporation, Novartis and Eli Lilly (NYSE: LLY)- to make it known that Intrasphere was a company poised for success.
BlinnPR employed a strategy of news announcements and by-line article pitches to persistently build a rapport with reporters and their audiences. As the customer roster began to grow, Intrasphere gave exclusive interviews to vertical and trade papers on the deployments of new offerings and pending FDA rulings.
After its first 12 months with BlinnPR, Intrasphere has seen publicity in more than 25 articles, with coverage in The Scientist, BioIT World, European Pharmaceutical Executive, CRN, Crain's New York Business, CIO Insight, Contract Pharma, and GCPj, among others.
|
 |
